The animal studies that used it report the doses administered (for example, 5 and 10 mg/kg in an aged-muscle regeneration study [2] ) and the biological outcomes, but they do not report plasma concentration-time curves, clearance, or elimination half-life for the molecule itself
However, groups switched from WD to LD (WD/LD-V, WD/LD-T) tended to show greater alpha diversity compared to the control groups (WD/WD-V and LD/LD-V), which was not surprising since these animals experienced the most diet transitions with variable nutrient resources during their lifetime
Early clinical trials have shown that AOD 9604 effectively promotes fat loss without causing the significant side effects often associated with growth hormone therapy [1]
Safety and Comfort Considerations Both options are considered safe when used appropriately
Not to be used in foods, drugs, or medical diagnostics